Medical researchers have partnered with Fitbit for the SleepSight study to learn about how sleep patterns affect schizophrenia patients, according to the Daily Mail.

‘With access to the Fitbit Partner API, we have the ability to “zoom” into our participant’s sleep and detect patterns in the single minute to second spectrum,’ continued the team.

‘We believe this partnership will allow us to significantly push our research forward and enable us to make more accurate detections and predictions of relapse in schizophrenia.’

The initial trial with run for two months and involve so-called ‘relatively stable’ patients not undergoing a relapse.

But specialist registrar in psychiatry Dr Nicholas Meyer told Wired that future studies will recruit ‘more unwell patients who may have a history of not taking medication’.

View the full story at